Histopathologic features of Mycobacterium ulcerans infection. - Wikidata - awgldk - TriplyDB

Histopathologic features of Mycobacterium ulcerans infection.

Histopathologic features of Mycobacterium ulcerans infection.

http://www.wikidata.org/entity/Q34396322

about

Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs Clinical and Laboratory Diagnosis of Buruli Ulcer Disease: A Systematic Review Development of highly organized lymphoid structures in Buruli ulcer lesions after treatment with rifampicin and streptomycin Secondary bacterial infections of buruli ulcer lesions before and after chemotherapy with streptomycin and rifampicin Dry-reagent-based PCR as a novel tool for laboratory confirmation of clinically diagnosed Mycobacterium ulcerans-associated disease in areas in the tropics where M. ulcerans is endemic Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease).Extrapulmonary infections associated with nontuberculous mycobacteria in immunocompetent persons.Serological evaluation of Mycobacterium ulcerans antigens identified by comparative genomics Experimental infection of the pig with Mycobacterium ulcerans: a novel model for studying the pathogenesis of Buruli ulcer disease.Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?Proteomic analysis of the action of the Mycobacterium ulcerans toxin mycolactone: targeting host cells cytoskeleton and collagen.Severe multifocal form of buruli ulcer after streptomycin and rifampin treatment: comments on possible dissemination mechanisms.Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice.Sensitivity of PCR targeting the IS2404 insertion sequence of Mycobacterium ulcerans in an Assay using punch biopsy specimens for diagnosis of Buruli ulcer.Sero-epidemiology as a tool to screen populations for exposure to Mycobacterium ulcerans.Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study Buruli ulcer.Corticosteroid use for paradoxical reactions during antibiotic treatment for Mycobacterium ulcerans.Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo.Cytokine mRNA expression in Mycobacterium ulcerans-infected human skin and correlation with local inflammatory response.Incidence, clinical spectrum, diagnostic features, treatment and predictors of paradoxical reactions during antibiotic treatment of Mycobacterium ulcerans infections.Identification of the Mycobacterium ulcerans protein MUL_3720 as a promising target for the development of a diagnostic test for Buruli ulcer.Mycobacterium ulcerans fails to infect through skin abrasions in a guinea pig infection model: implications for transmission.Combined inflammatory and metabolic defects reflected by reduced serum protein levels in patients with Buruli ulcer disease Combining PCR with microscopy to reduce costs of laboratory diagnosis of Buruli ulcer Shaping mycolactone for therapeutic use against inflammatory disorders.Evidence for an intramacrophage growth phase of Mycobacterium ulcerans.Chemotherapy-associated changes of histopathological features of Mycobacterium ulcerans lesions in a Buruli ulcer mouse model.Interferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice.Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model.Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone.Analysis of Mycobacterium ulcerans-specific T-cell cytokines for diagnosis of Buruli ulcer disease and as potential indicator for disease progression.Mycolactone activation of Wiskott-Aldrich syndrome proteins underpins Buruli ulcer formation.Immunoglobulin M antibody responses to Mycobacterium ulcerans allow discrimination between cases of active Buruli ulcer disease and matched family controls in areas where the disease is endemic.Mycolactone-mediated neurite degeneration and functional effects in cultured human and rat DRG neurons: Mechanisms underlying hypoalgesia in Buruli ulcer Mycolactones: immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteria.Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans.Mycolactone subverts immunity by selectively blocking the Sec61 translocon.Laboratory diagnosis of Buruli ulcer disease.

P2860

Q21090122-850183A1-E297-4E3B-A117-D5E2DBBC964B Q26740428-DA02A77A-6B35-496E-AD7A-9EA0E808FAF0 Q28469338-5531B106-43C8-42B6-AA10-85AC4E557DA9 Q28487505-180F634B-63AD-41F6-B7B8-E705FC58E02A Q33592557-19DFCDC2-441F-4AA3-B558-2F91C69BC0E7 Q33631299-B21B5F2E-DB99-420B-8E2F-3489E0AF4CCB Q33644586-85E14704-22EB-4038-8D7C-D7E0FDD90281 Q33745230-BAF2EC34-147F-4D25-AFC1-B12A631078F3 Q33881961-56AAF391-7DE9-4990-8E68-EF73BA520459 Q33988898-849BB985-F682-4FD5-9982-9DF443FDBAE3 Q34016179-2757AE12-1507-4E87-BC2A-AE5ECB9FE07E Q34024822-697B2D80-B10D-442B-929D-BD64D924534C Q34033119-4B9AA212-03C5-48AD-9ADE-CAA55E47143A Q34041583-6DDC2D34-143B-4350-B135-05E84CC3BB99 Q34131228-8E9C404A-5067-4B59-AA0F-15D48E3341D4 Q34137837-593DEB6F-A37A-45F2-92ED-A81703FA55AC Q34229628-AD8DA075-CAB0-4808-BB41-0A4CFBADE672 Q34431496-779B6DB5-10EF-4A2E-9134-10BC2A104EE9 Q34442650-7F66EC9E-872E-411D-9373-5A93AF2E0090 Q34602038-89FA8F8B-5149-4470-B265-D34E2C636E9B Q34978950-119CEDE8-EB36-4056-AB69-3A888452B48E Q35130938-F248B2E4-1713-4125-B623-2B4D15D0A307 Q35145362-0A232385-25F4-4485-A3E7-D72C0D74979D Q35145483-2443099D-ECCA-4525-B704-3D6ADD4420F2 Q35494532-3E3FA36F-6B0D-48AA-8517-7C50980B39CA Q35644283-920996BC-DC4D-453D-B959-09254CB46869 Q35689228-39781866-A90F-4EE4-9923-EB2BBC3EC714 Q35689285-9D3E696A-63E4-4535-8CE4-DF6F761EEA31 Q35919532-FD18826F-2EEA-4119-9040-7E02A5D93452 Q35949741-B4E7793B-04A2-4BF6-AD43-1BD8A5B3A102 Q36002996-4E089E40-5A78-4196-A3BC-8C098E8260FC Q36229394-34E4E4A4-A714-4C3D-9462-73418BEA6432 Q36291527-8A9EA3B7-A9F4-4921-ADE3-99C91F238E45 Q36733497-D3B822BC-7D29-4542-8100-25DD7256AED8 Q37015337-23814070-34AE-4EDF-801D-77B6F7C3D7B6 Q37115277-25FA11E3-E632-4E9B-B888-7B551C631B26 Q37170768-75A9A3DC-B8C6-4722-A877-E898C45359FA Q37349850-2EA20360-891B-4C53-90E0-C6A1CDD6E521 Q37500335-105B2F7E-D77A-4D21-9DF4-8969AD0787EE Q37704358-6CBE6784-80E9-4B1B-91BE-92F0F4507D3C

P2860

Histopathologic features of Mycobacterium ulcerans infection.

http://www.wikidata.org/entity/Q34396322

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Histopathologic features of Mycobacterium ulcerans infection.

@ast

Histopathologic features of Mycobacterium ulcerans infection.

@en

Histopathologic features of Mycobacterium ulcerans infection.

@nl

type

label

Histopathologic features of Mycobacterium ulcerans infection.

@ast

Histopathologic features of Mycobacterium ulcerans infection.

@en

Histopathologic features of Mycobacterium ulcerans infection.

@nl

prefLabel

Histopathologic features of Mycobacterium ulcerans infection.

@ast

Histopathologic features of Mycobacterium ulcerans infection.

@en

Histopathologic features of Mycobacterium ulcerans infection.

@nl

P1433

Q34396322-85491200-7E3B-461A-B10B-E7511E5EF9EC

P1476

Q34396322-94ED0737-3C09-4E6F-8CF6-CBC3B3814DC8

P2093

Q34396322-041F2E6E-593B-4595-B95D-41B64A67C2F1

Q34396322-08F9947A-DBF3-4C1A-BB91-2392947AAFC1

Q34396322-0C19717E-31B2-45E1-BAD1-29E055E65838

Q34396322-10A36795-FE85-4CE5-939F-5E1D529D0B33

Q34396322-2B5CF8DE-6BB2-45BE-AA68-C002891F5163

Q34396322-35AD8ADD-1484-4416-B369-87A0AA202B74

Q34396322-4F798F2F-B811-4E98-9127-C7CAD20B713C

Q34396322-66DC9F8A-CBE1-49EA-9A19-F9DD8B6E6101

Q34396322-71888D29-4E8A-498D-AAE0-F8888A71C985

Q34396322-766AC89D-B55D-45CD-BDAB-8D0CCA48675F

P2860

Q34396322-12B37A4D-56D2-469D-9D22-5CD3281A22CF

Q34396322-1E4D9D0B-16C6-4C9F-94E8-69D94440BD7A

Q34396322-2D6A6F65-AF6B-4DBC-B333-EA82F729EF4D

Q34396322-2E25635C-F6D2-4245-A4AB-4077D9B45026

Q34396322-41A50A46-C1A2-46F1-AE77-0D606296E16F

Q34396322-4BE5DC6A-CC7C-475B-9411-CBFFF20469EA

Q34396322-69EFC7AC-8737-4D4E-B1C6-814F9A66A712

Q34396322-81A31EC1-67FD-4C7E-BD5C-AB74C5B57061

Q34396322-8C1F28DC-0C25-4170-8262-2AA213C97D21

Q34396322-9CE44B93-DE1B-435C-A525-80B6C4E863AC

P304

Q34396322-9828938F-8D29-49B1-A1B1-504B773F4124

P31

Q34396322-8A784B3D-6AD6-4EE2-B731-301A2861898A

P356

Q34396322-3C094DF2-1710-4757-B8C5-01E33A9C13FD

P433

Q34396322-33F9273F-9A45-463A-9FF2-BD88315A1414

P478

Q34396322-0855C0CD-305C-4F38-A8B4-5A2AAB07812B

P577

Q34396322-C00B825C-D3EA-461C-A191-E5CAE5FA894D

P5875

Q34396322-56A46721-4131-4137-92D2-0B449D37A8A9

P698

Q34396322-7A25EDFE-F06E-4AFB-A6E8-7E2587343D6C

P921

Q34396322-B9B0CE29-4209-4E2D-940E-5904F1D28829

P932

Q34396322-0D8EDBB0-9442-46FC-8EFA-C40FEC7D9FAE

P356

P1433

Emerging Infectious Diseases

P1476

Histopathologic features of Mycobacterium ulcerans infection.

@en

P2093

C Harold King

http://www.w3.org/2001/XMLSchema#string

David A Ashford

http://www.w3.org/2001/XMLSchema#string

Ellen A Spotts Whitney

http://www.w3.org/2001/XMLSchema#string

Erasmus Klutse

http://www.w3.org/2001/XMLSchema#string

Eric Quarshie

http://www.w3.org/2001/XMLSchema#string

Jeanine Bartlett

http://www.w3.org/2001/XMLSchema#string

Jeannette Guarner

http://www.w3.org/2001/XMLSchema#string

Kwame Asamoa

http://www.w3.org/2001/XMLSchema#string

Pratima L Raghunathan

http://www.w3.org/2001/XMLSchema#string

Samuel Etuaful

http://www.w3.org/2001/XMLSchema#string

P2860

Mycobacterium ulcerans cytotoxicity in an adipose cell model

Comparison of two PCRs for detection of Mycobacterium ulcerans

Direct detection and identification of Mycobacterium ulcerans in clinical specimens by PCR and oligonucleotide-specific capture plate hybridization

Buruli ulcer in Ghana: results of a national case search

Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence

Mycobacterium ulcerans infection.

Partial purification and characterization of biological effects of a lipid toxin produced by Mycobacterium ulcerans.

Human Mycobacterium ulcerans infections developing at sites of trauma to skin.

Analysis of an IS2404-based nested PCR for diagnosis of Buruli ulcer disease in regions of Ghana where the disease is endemic.

MYCOBACTERIAL SKIN ULCERS IN UGANDA: HISTOPATHOLOGICAL AND EXPERIMENTAL ASPECTS.

P304

651-656

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID0906.020485

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2003-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10730504

http://www.w3.org/2001/XMLSchema#string

P698

12780997

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium ulcerans

P932

3000137

http://www.w3.org/2001/XMLSchema#string